Solubility-Improved 10-O-Substituted SN-38 Derivatives with Antitumor Activity.

about

Solubility-Improved 10-O-Substituted SN-38 Derivatives with Antitumor Activity.

Item

http://www.wikidata.org/entity/Q47892420

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Solubility-Improved 10-O-Substituted SN-38 Derivatives with Antitumor Activity.

@en

Solubility-Improved 10-O-Substituted SN-38 Derivatives with Antitumor Activity.

@nl

type

Item

label

Solubility-Improved 10-O-Substituted SN-38 Derivatives with Antitumor Activity.

@en

Solubility-Improved 10-O-Substituted SN-38 Derivatives with Antitumor Activity.

@nl

prefLabel

Solubility-Improved 10-O-Substituted SN-38 Derivatives with Antitumor Activity.

@en

Solubility-Improved 10-O-Substituted SN-38 Derivatives with Antitumor Activity.

@nl

P1476

Solubility-Improved 10-O-Substituted SN-38 Derivatives with Antitumor Activity.

@en

P2093

Kosuke Nishino

http://www.w3.org/2001/XMLSchema#string

Masatoshi Nakatsuji

http://www.w3.org/2001/XMLSchema#string

Shiho Sakamoto

http://www.w3.org/2001/XMLSchema#string

Shota Shimizu

http://www.w3.org/2001/XMLSchema#string

Takashi Inui

http://www.w3.org/2001/XMLSchema#string

Tatsuya Kida

http://www.w3.org/2001/XMLSchema#string

Yasuhisa Tamura

http://www.w3.org/2001/XMLSchema#string

Yoshiaki Teraoka

http://www.w3.org/2001/XMLSchema#string

Yosky Kataoka

http://www.w3.org/2001/XMLSchema#string

P2860

Human Lipocalin-Type Prostaglandin D Synthase-Based Drug Delivery System for Poorly Water-Soluble Anti-Cancer Drug SN-38

Irinotecan (CPT-11): recent developments and future directions--colorectal cancer and beyond.

Irinotecan and its active metabolite, SN-38: review of bioanalytical methods and recent update from clinical pharmacology perspectives.

Review of the role of CPT-11 in the treatment of colorectal cancer.

Irinotecan: mechanisms of tumor resistance and novel strategies for modulating its activity.

Cancer therapies utilizing the camptothecins: a review of the in vivo literature

Molecular imaging with PET.

Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography.

Development and characterization of a novel liposome-based formulation of SN-38.

Novel delivery of SN38 markedly inhibits tumor growth in xenografts, including a camptothecin-11-refractory model.

P304

1715-1722

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CMDC.201700454

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hisashi Doi

P577

2017-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28891271

http://www.w3.org/2001/XMLSchema#string